CAS: 958002-33-0 - Bms 791325
Fórmula:C36H45N5O5S
InChI:InChI=1S/C36H45N5O5S/c1-38(2)47(44,45)37-34(42)23-10-14-28-31(16-23)40-21-36(35(43)41-24-11-12-25(41)20-39(3)19-24)18-30(36)29-17-26(46-4)13-15-27(29)33(40)32(28)22-8-6-5-7-9-22/h10,13-17,22,24-25,30H,5-9,11-12,18-21H2,1-4H3,(H,37,42)/t24?,25?,30-,36-/m0/s1
Clave InChI:InChIKey=ZTTKEBYSXUCBSE-VSBZUFFNSA-N
SMILES:O=C(NS(=O)(=O)N(C)C)C1=CC=C2C(=C1)N3C(C=4C=CC(OC)=CC4C5CC5(C(=O)N6C7CN(C)CC6CC7)C3)=C2C8CCCCC8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Beclabuvir REF: 3D-INB00233CAS: 958002-33-0 | Min. 95% | A consultar | Mar 18 Feb 25 |
 | Beclabuvir REF: TM-T10493CAS: 958002-33-0 | 99.87% - 99.93% | A consultar | Mar 08 Abr 25 |
Beclabuvir
CAS:958002-33-0
Beclabuvir is a novel antiviral drug that inhibits the enzyme human immunodeficiency virus (HIV) integrase. …
Fórmula:
C36H45N5O5S
Pureza:
Min. 95%
Peso molecular:
659.84 g/mol
Ref: 3D-INB00233
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
Beclabuvir
CAS:958002-33-0
Beclabuvir blocks HCV NS5B polymerase at thumb site 1, effective on genotypes 1, 3, 4, …
Fórmula:
C36H45N5O5S
Pureza:
99.87% - 99.93%
Forma y color:
Solid
Peso molecular:
659.84
Ref: TM-T10493
| 1mg | 133,00 € |
Entrega estimada en Estados Unidos, el Martes 8 de Abril de 2025
